Periodic monitoring Active

Key facts

  • In March 2026, 30 EU/EEA countries reported measles data. Twelve countries reported 172 cases and 18 countries reported zero cases.
  • During the 12-month period, five deaths attributable to measles were reported to ECDC by France (3), the Netherlands (1) and Romania (1).
  • Overall, case numbers increased compared with the previous month.
  • Complementary epidemic intelligence surveillance was performed on 20 May 2026. Outbreaks have been reported in Bulgaria, France and Portugal. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA.

Overview

In March 2026, 30 EU/EEA countries reported measles data. Twelve countries reported a total of 172 cases and 18 countries reported zero cases.

Overall, case numbers increased compared with the previous month; however, this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Bulgaria (52), Italy (44), Spain (24), France (15) and Germany (11).

In the most recent 12-month period, from 1 April 2025 to 31 March 2026, 30 EU/EEA countries reported a total of 3 607 cases of measles, 3 098 (85.9%) of which were laboratory confirmed.

Of the 3 607 cases with known age, 1 143 (31.7%) were in children under five years; 1 627 (45.1%) cases were in those aged 15 years or above. The highest notification rates were observed among infants under one year of age (90.8 cases per million) and children aged 1-4 years (48.9 cases per million).

Of 3 029 individuals (84.0% of all cases) with a known age and vaccination status, 2 369 (78.2%) were unvaccinated, 320 (10.6%) were vaccinated with one dose of a measles-containing vaccine, 301 (9.9%) were vaccinated with two or more doses, and 32 (1.1%) were vaccinated with an unknown number of doses.

During the 12-month period, five deaths (case fatality rate (CFR): 0.139%) attributable to measles were reported to ECDC by France (3), the Netherlands (1) and Romania (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance was performed on 20 May 2026. Outbreaks have been reported in Bulgaria, France and Portugal. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA. Outside the EU/EEA, updates have been provided by England, Bangladesh, Ukraine, Africa CDC, the World Health Organization Pan American Health Organization (WHO PAHO), Canada, the United States (US), Mexico and Japan.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Bulgaria is experiencing an ongoing outbreak, with 277 cases of measles reported from 1 January to week 20 2026 (week ending 17 May). According to media, quoting the Ministry of Health on 4 May 2026, most of the cases are reported in the Vratsa region (150), followed by Pleven (48), Lovech (18), Sofia city (4), Varna (3), Montana (1) and Sofia (1). The majority of the cases are in children (189/225). The outbreak began on 19 March 2026. Over 28 000 MMR vaccine doses have been administered in response to the outbreak. In 2025, Bulgaria reported two cases.

 

Estonia reported one new case since 10 March 2026, with three cases reported in total as of 20 May 2026.

France reported 77 cases of measles and no deaths between 1 January and April 2026, an increase of 49 cases since the end of February. The cases were reported among both children and adults. The number of cases in the reporting period is lower than in the same period last year. Half of the cases (54%) for whom vaccination status was known (28/52), were not fully vaccinated. At least one case was reported in 24 departments of France, with most of the cases reported in Yvelines (10%), Moselle (9%), Hauts-de-Seine (9%), Meurthe-et-Moselle (8%), Paris (8%) and Essonne (8%). No cases have been reported in overseas territories of France. Overall, 12 outbreaks were reported and three outbreaks are still active.

Germany reported 82 confirmed and probable measles cases in 2026 (weeks 1 to 21), an increase of 23 cases since week 15.

Latvia reported 49 confirmed measles cases related to an outbreak, as of data from 15 April 2026, an increase of two case since the previous report on 10 April. No new cases were reported since then.

 

Lithuania reported seven cases from 1 January to 19 May 2026.

Poland reported 17 cases from 1 January to 15 May 2026.

Portugal is experiencing an outbreak of measles, with three cases and around 500 identified contacts reported in Beja (according to a media report on 18 May 2026).

Spain reported 118 cases of measles from 1 January to 17 May 2026, including 10 imported cases and 25 cases related to imported cases. This represents an increase of 21 cases since April 2026.

Sweden reported five cases in 2026, as of 20 May 2026.

 Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

No new outbreaks or cases have been detected in the reporting period.

Western Balkan countries and Türkiye

No new outbreaks or cases have been detected in the reporting period.

Epidemiological summary for selected countries outside of the EU/EEA with relevant epidemic intelligence updates:

Ukraine reported 132 cases from January to March 2026. In 2025, Ukraine reported 1 502 measles cases from January to December 2025.

England reported 542 laboratory-confirmed cases and no deaths, between 1 January and 27 April 2026.

Bangladesh is experiencing the following: On 20 May 2026, media, quoting health authorities, reported 57 856 children with measles-like symptoms, including 8 067 with confirmed measles diagnosis since 15 March (an increase of over 6 000 cases since the report on 13 May). Among the reported cases, there are 481 deaths, including 80 deaths with confirmed measles. During this period, 45 128 children were hospitalised, the vast majority of whom have recovered. Measures are being implemented by national authorities in collaboration with international organisations.

Africa CDC reported on 3 May 2026 that, overall, in 2026 there have been 3 422 confirmed and 92 537 suspected cases of measles and 633 deaths from 21 African Union Member State countries. High risk of measles spread is listed for Mali and Senegal, and moderate risk in Burundi, the Democratic Republic of the Congo and Mozambique.

 

According to the WHO Pan American Health Organization (WHO PAHO) report published on 25 April 2026, 18 088 confirmed measles cases have been reported by 14 countries, of which the majority of cases are reported in Mexico (10 049), Guatemala (5 112), the US (1 811) and Canada (944). Due to the upcoming FIFA World Cup 2026, a more detailed overview is provided for the hosting countries: Canada, Mexico and the US.

 

Canada reported 1 018 measles cases (941 confirmed) and no deaths across seven jurisdictions in 2026 and as of 19 May 2026. The country remains in active transmission across multiple provinces due to an ongoing multijurisdictional outbreak. The vast majority of the cases reported in 2026 are linked to this outbreak.

The US continues to face multiple concurrent outbreaks, including several that began in 2025 and continue into 2026. Overall, the US Centers for Disease Control and Prevention (US CDC) reported 1 893 cases and no deaths between January and 14 May 2026 (vs a total of 2 287 cases, including three deaths, in 2025). In the same period, there were 27 new outbreaks reported and 93% of confirmed cases are outbreak associated. The majority of the cases are in children (72%) and unvaccinated individuals (92%).

Mexico reported on 19 May 2026, that overall since the beginning of the outbreak in 2025, 17 553 confirmed cases were reported, including 40 deaths. In 2026, Mexico reported 10 945 confirmed cases and 13 deaths. The number of cases is declining after a peak reported in week 6 in 2026. The most-affected state in 2026 is still Jalisco (9 847 cases; three deaths).

Japan is experiencing an increase of measles cases in 2026. With 479 cases reported in weeks 1–19, the number of cases exceeds the total reported in the whole year of 2025 (N=265). The largest number of cases (70) was reported in week 17. Preliminary data suggest 86% of the cases are in teenagers and adults. Of the reported cases, 38 were imported and 351 are considered as domestic cases.

For more information on the provisional number of cases outside the EU/EEA region, please visit the World Health Organization (WHO) website.

The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Continued vigilance is essential due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, possible introduction from areas with ongoing transmission, and increased travel and population movement during holiday periods.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs of measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for measles-containing vaccines (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with populations underserved by healthcare services. Systemic barriers that affect vaccine uptake in populations that are isolated and underserved by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up-to-date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all